A Rapidly Changing Regulatory Landscape: What Medical Affairs Leaders Should Know
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.
The MAPS Puerto Rico Roundtable hosted by Real Chemistry in March 2024 discussed the integration of digital platforms, AI, and personalized content to enhance engagement with healthcare providers (HCPs). The panel emphasized the shift towards real-time, tailored information delivery and the importance of leveraging insights from both traditional and digital sources to support effective engagement strategies while ensuring compliance.